Member Info for Lp160606

Cares about PI's? Pull the other one.

Being CEO of a public company part of the job spec is communicating with shareholders!

Hasn't said f all for months. One grey as anything response about going after the 'big deal'. Come on man, glue your heads on.

Thanks for sharing PP but it means absolutely nothing. He responded because the PI who sent it basically led him for an easy out if the question was around 'are you attempting to land bigger deals, is that why we have had such a delay?' It is such an easy answer.

Pretty small window of opportunity now

I'm not looking forward to the results, but am the Q&A.

Will be very interesting, I hope he presents a roadmap slide.

Just very little volume tbf so range bound awaiting news.

Should know by the end of the month.

There is definitely still money to be made in diagnostics.

But we currently do not even have approval to sell in our targeted geographies. There is more to it then we have been told, that I am sure of.

Its disappointing as if no news drops prior to results a further 15/20% will be wiped off (in my view) this view is formed of comparatively looking at ODX post results - they had poor half year and dropped 15-20%..

lol alright.

What material value have you added to shareholders since achieving CE Mark?

sorry i couldn't stick to just one...

Good question.

He can wriggle out of any approval enquiry by stating it is out of his hands... also around contracts the answer will be 'we would of RNS'd any material contract'

So my questions would be centred on Beckman & the placement money spend.

In a personal email to me you stated the desire to have Beckman validate internally (equally in an RNS), confirming in a later mail that if Beckman validate and absolve us into their lab system we bypass FDA due to becoming LDT via Beckman's validation. In the latest RNS you placed great enthuses on the requirement to achieve FDA before any go live date.

What changed during the validation process to make FDA now a requirement?

Also, what is the process of Saliva validation and at what stage are GDR at?

Then finally,

'Please provide a breakdown of the use of funds provided in the May breakdown'

These questions allow for 0 bull**** and is why they will not be addressed.

They have done 3 mid morning RNS since i have been in here. About 8 weeks.

the Mid morning ones have always been operational updates @ Clagua (i believe), would envisage results would be a 7am but unsure - just my thoughts.

I have but i don't think any of my questions will be answered.

Problem with allowing each investor to list 8 questions is they will pick the easiest ones to answer.

There is however a stark difference. NCYT have secured very lucrative revenue streams, we have not.

Holy sh*t...

I just looked at them myself. Awful. Suggests a complete scam.

@Midsummer,

There are plenty.

TLW / PMO / CINE / SHI

They are the only 4 i have been following.

https://www.biorxiv.org/content/10.1101/2020.11.04.355842v1

https://www.thailandmedical.news/news/covid-19-mutations-international-study-warns-of-more-strains-emerging-that-can-evade-human-immune-response,-new-n439k-mutation-is-a-concern--

Worth reading second link, was posted on NCYT.

Here are the boys look haha.

Almost as if they read the board... few mutters of silence and a gentle reminder presents itself.

Anyone watching the briefing?

Suggesting a rollout of said vaccine much further away than a month.. running through the stages of authorisation.. preparing the public for a pushed date..

Test, test, test.

fair assessment.

Sales required In my view. I do not think approvals are enough, sales need to fall alongside the various approvals to bolster the SP.

Btw been reading on ODX that gov are releasing tender winners @ 0930 today...

I am not 100% sure what these tenders are for but could be of interest.

lol ffs.

That is not a good look. Why not wait a few months if its that good, will no doubt add a few more billion to the Mcap?

Or perhaps he understands the logistical nightmare this vaccine presents, not just in storing but administering multiple doses and you know, considering it doesn't have viable data (as in study is not concluded) as of yet thought this was the optimal time to dump..

Interesting and adds another factor.

Great news. They aren't launching a Covid test for a 3 month cash grab are they!